Form 4: Hans Peter Wild Reports Acquisition of ADC Therapeutics SA Shares
SEC Form 4 Filing
Hans Peter Wild reports acquiring 9,788,944 common shares of ADC Therapeutics SA on May 15, 2025.
Summary
- On May 15, 2025, Hans Peter Wild reported acquiring 9,788,944 common shares of ADC Therapeutics SA.
- The shares are held both directly and indirectly through HP Wild Holding AG and HPWH TH AG.
- Thomas Pfisterer transferred his ownership of 451,856 shares in HPWH following his resignation from the Board of HPWH.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a change in ownership. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing reflects changes in beneficial ownership of a significant shareholder in a publicly traded company, ADC Therapeutics SA, which is common in the biopharmaceutical industry.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of transaction: Hans Peter Wild acquired 9,788,944 common shares of ADC Therapeutics SA. |
| 05/15/2025 | Date of report: Hans Peter Wild reported the acquisition of shares. |
Keywords
ADC Therapeutics SA, Hans Peter Wild, share acquisition, Form 4, beneficial ownership, HP Wild Holding AG, HPWH TH AG, securities, transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.